- Home
- CHGG vs FORA Comparison
CHGG vs FORA Comparison
Compare CHGG & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHGG | FORA |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Computer Software: Prepackaged Software |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.6M | 66.2M |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CHGG | FORA |
|---|---|---|
| Price | $0.70 | $2.08 |
| Analyst Decision | Sell | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 784.0K | 12.2K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.15 | 25.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $376,908,000.00 | $30,256,919.00 |
| Revenue This Year | N/A | $51.82 |
| Revenue Next Year | N/A | $7.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 50.13 |
| 52 Week Low | $0.44 | $1.64 |
| 52 Week High | $1.89 | $2.71 |
Technical Indicators
Market Signals| Indicator | CHGG | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 59.09 | 50.79 |
| Support Level | $0.53 | $2.04 |
| Resistance Level | $0.83 | $2.12 |
| Average True Range (ATR) | 0.06 | 0.02 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 73.19 | 75.00 |
Price Performance
Historical ComparisonAbout CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Chegg Skilling; and Academic Services, which derives maximum revenue. Geographically, it derives in United States and International.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.